At the Virtual 2020 ESMO Congress, Ana Carneiro talks about disparities in access to oncology trials from the last decade. The late-breaking abstract ‘Disparities in access to oncology clinical trials in Europe in the period 2009-2019‘ (LBA66) was presented at the Virtual 2020 ESMO Congress, 19–21 September 2020.
Questions
- Prior to this study, what was already known about disparities in cancer care and clinical trials across Europe? (0:14)
- Could you tell us a little about the aims and design of this study on access to oncology trials? (0:46)
- What were the findings of this study? (1:20)
- What are the limitations impacting access in clinical trials across European countries? (1:58)
- What can be done to address these inequalities? (2:48)
Speaker Disclosure: Ana Carneiro has nothing to disclose in relation to this interview.
Support: Interview and filming supported by Touch Medical Media Ltd.
Filmed in coverage of the Virtual 2020 ESMO Congress.
